Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the conjugate vaccine market grown in recent years?

The market size of conjugate vaccines has seen significant expansion in the past few years. Analysts predict an increase from $18.9 billion in 2024 to $21.46 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.5%. Factors that have driven growth during the historic period include the burden of disease, governmental vaccination initiatives, heightened awareness of the issue, a focus on vaccinations for children, and a trend towards preventive healthcare.

How is the conjugate vaccine market size expected to evolve during the forecast period?

In the coming years, the conjugate vaccine industry is predicted to witness a substantial expansion, culminating to an expected size of $34.59 billion by 2029, with a compound annual growth rate (CAGR) of 12.7%. Factors contributing to this predicted growth during the projected period include extensive immunization strategies, changes in the elderly population, introduction of new vaccine indications, concerns over global health safety, international co-operation, and the repercussion of economic development. Various trends set to dominate the anticipated period comprise collaborations and alliances for the distribution of vaccines, bespoke methods for more vulnerable demographics, use in controlling new infectious diseases, advancements in vaccine production technology, and worldwide health agendas aiming for equal vaccine distribution.

Get your conjugate vaccine market report here!

https://www.thebusinessresearchcompany.com/report/conjugate-vaccine-global-market-report

Which key drivers are propelling the conjugate vaccine market’s growth?

The conjugate vaccine market is set to see significant growth due to the rising utilization of conjugate vaccines in adults. Designed to elicit potent immune reactions against bacterial capsular polysaccharides, conjugate vaccines bolster the body’s defensive capabilities against bacterial infections. Injecting adults with conjugate vaccines mitigates the potential for severe disease, complications, and the spread of bacterial illnesses by promoting a strong immune reaction. For instance, data from the UK Health Security Agency (UKHSA) in June 2024 indicated that the ‘6-in-1’ vaccine coverage in the UK remained steady at 91.7% over 12 months. The primary dose of the pneumococcal conjugate vaccine (PCV) held steady at 93.7%. The coverage for the rotavirus vaccine experienced a 0.6% increase, hitting 89.3%, while the second dose of the meningitis B vaccine (MenB2) saw an increase of 0.1%, achieving 91.5%. Hence, the expanded application of conjugate vaccines amongst adults is steering the expansion of the conjugate vaccine market.

What are the market segments in the conjugate vaccine industry?

The conjugate vaccine market covered in this report is segmented –

1) By Product Type: Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine

2) By Pathogen: Bacterial, Viral

3) By Disease Indication: Pneumococcal, Influenza, Meningococcal, Typhoid

4) By Patient: Pediatric, Adults

5) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Monovalent Conjugate Vaccines: Single Pathogen Conjugate Vaccines

2) By Multivalent Conjugate Vaccines: Multiple Pathogen Conjugate Vaccines, Combination Conjugate Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10850&type=smp

Which leading companies are shaping the growth of the conjugate vaccine market?

Major companies operating in the conjugate vaccine market include Sanofi S.A., Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Biological E. Limited, Bavarian Nordic A/S, CSL Limited, Novartis AG, GreenSignal Bio Pharma Limited, Taj Pharmaceuticals Limited, Vaxcyte Inc., Neuron Biotech Co. Ltd., Bio-Med Pvt. Ltd., Sinovac Biotech Ltd., Takeda Pharmaceutical Company Limited, Valneva SE, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Panacea Biotec Ltd., Protein Sciences Corporation, Seqirus

What key trends are currently impacting the conjugate vaccine market’s development?

The trend of innovation within the sphere of conjugate vaccines is becoming increasingly prevalent in the conjugate vaccine market. Companies that are active in this field are channeling their efforts in inventing novel conjugate vaccines in an attempt to maintain their footing in the market. Pfizer Inc., an American pharma and biotech firm, for example, introduced Prevnar 20, a pneumococcal 20-valent conjugate vaccine that targets pneumonia and invasive pneumococcal infections in adults of 18 years and older, in Canada in June 2022. Prevnar 20 consists of conjugates for the existing 13 serotypes covered by PREVNAR 13, along with additional conjugates for seven other serotypes linked to invasive pneumococcal disease, severe case-fatality rates, antibiotic resistance, and meningitis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10850

Which geographic areas are influencing the growth of the conjugate vaccine market?

North America was the largest region in the global conjugate vaccine market in 2024. The regions covered in the conjugate vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Dog Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: